Interview: Bill Doherty – MD, Cook Ireland and EVP of Cook Group Europe,…
Bill Doherty, MD of Cook Ireland and EVP of Cook Group Europe, one of the largest private medical device companies in the world, discusses his main priorities at the moment,…
Address: Takeda Ireland Limited (Bray), Bray Business park, Kilruddery, Co. Wicklow, ,Ireland
Tel: +353 (0)1 2050600
Takeda Ireland Limited (TIL) is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, a global research-based pharmaceutical company, the No 1 pharmaceutical company in Japan, and one of the world’s top 100 companies.
Established in Ireland since 1997, Takeda employs over 400 people in the following areas: manufacturing of drug products (DP), active pharmaceutical ingredients (API), process development, packaging, supply chain, sales and marketing.
Takeda Ireland Ltd – Bray (DP)
TIL Bray, a wholly-owned subsidiary of Takeda Pharmaceutical Company has played a key role in Takeda’s worldwide operations since being established in 1997. To date employing over 400 people and serving as the main pharmaceutical production base for blockbuster products to the European and U.S markets.
Takeda Ireland Ltd – Grange Castle (API)
In 2002 the first Takeda API (Active Pharmaceutical Ingredient) plant outside Japan was constructed in Clondalkin, Dublin 22, representing a key strategic addition to the group’s global production network. The plant will be the launch vehicle for new strategic products for global markets developing and producing API’s from clinical trial stages through to launch and full commercialisation.
Takeda Products Ireland Ltd
Based in Citywest, Takeda Products Ireland Limited was established to market Takeda’s products throughout the Republic of Ireland. Takeda Products Ireland Limited is dedicated to improving Irish patients’ lives by bringing to the market, new and better medicines, developed by Takeda and key partners, to help address the nation’s most pressing healthcare needs. This includes debilitating conditions in key areas such as Cancer, Pulmonary disease, Cardiovascular disease, Type II Diabetes and Pain Management. Our current product portfolio includes Prostap, Mepact, Actos, Competact, Blopress, Blopress Plus, Edarbi, Midon, Instanyl, Matrfien, Xeforapid, Daxas, Protium, Somac Control, Preotact, Alvesco and Tachosil.
Prostap, Mepact, Actos, Competact, Blopress, Blopress Plus, Edarbi, Midon, Instanyl, Matrfien, Xeforapid, Daxas, Protium, Somac Control, Preotact, Alvesco and Tachosil.
Bill Doherty, MD of Cook Ireland and EVP of Cook Group Europe, one of the largest private medical device companies in the world, discusses his main priorities at the moment,…
Donal O’Callaghan, founder and CEO of Callaghan Engineering, an Irish engineering and construction firm, tells us what motivated him to break into the pharma market in 1990, the changes in…
Frederic Secail, General Manager of Servier’s second strategic and international production facility within Servier Industry, located in Arklow, Ireland, outlines his ambitious transformation program, Arklow 2020, to anticipate and prepare…
Shane Ryan, in his first month as Country Lead for Takeda Products Ireland, speaks about his mandate to position Takeda as the leader in IBD and oncology with exciting new…
Dan McAlister and Ramy Michael, two of EIDA Solutions’ cofounders, tell us the exciting story behind EIDA Solutions’ rapid growth to become one of the best intelligent construction software companies…
James Lennertz, Group VP and GM EUMEA for BioMarin, discusses the key highlights of the past few years for BioMarin, their unique positioning as a company offering innovative therapies for…
Donal Higgins, MD of Prochem Engineering, provides an overview of their life sciences operations, the key innovations they are bringing to the industry like computational fluid dynamics (CFD), and his…
Deirdre Bourke, Country Lead at Eli Lilly’s Irish affiliate, highlights the strategic importance of Ireland to Lilly’s global operations, their exciting upcoming pipeline, the challenges and opportunities she foresees for…
Paula O’Neill, co-founder and MD of Premium Power, an Irish electrical consultancy, highlights the importance of having safe, resilient and efficient electrical systems, particularly in high-tech industries like pharmaceutical manufacturing,…
Iwer Baecker, MD of Bayer Ireland, outlines the Irish affiliate’s impressive growth in the past few years, the strategy of New Bayer and how it comes into play in Ireland,…
Philip Martin, founder and CEO of Irish E-PPM software provider, Cora Systems, outlines his company’s successful growth in the past two decades, his bold plans for expansion into the US…
Chairman for BioPharmaChemical Ireland and Leader of Pfizer’s two small molecule API manufacturing sites in Cork, Seamus Fives recounts his team’s efforts to avert the closure of the Little Island…
See our Cookie Privacy Policy Here
